Macrogen, Inc., Propath UK, and Sirona Dx Add CosMx Spatial Molecular Imager to Meet Growing Demand for Spatial Biology Tools for Drug Developers
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, announced today three new Contract Research Organization (CRO) CosMxTM Spatial Molecular Imager partnerships. Macrogen, Propath UK, and Sirona Dx offer global biopharma customers new access to CosMx™ SMI technology for translational drug development. These specialty CROs provide biomarker testing services for drug developers and academic research institutions.
https://finance.yahoo.com/news/nanostring-expands-partnerships-contract-research-100000479.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.